67 Results for "

Fatty Acid Amide Hydrolase

" in MedChemExpress (MCE) Product Catalog:
Products (67)

67 Results for "Fatty Acid Amide Hydrolase" in MCE Product Catalog:

17
17 Publications Verification
Cat. No.: HY-14595
CAS No.: 491-80-5
Purity:  99.29%
Synonyms: 4-Methylgenistein; Olmelin
Biochanin A is a naturally occurring fatty acid amide hydrolase (FAAH) inhibitor, which inhibits FAAH with IC50s of 1.8, 1.4 and 2.4 μM for mouse, rat, and human FAAH, respectively.
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-B0182
CAS No.: 61422-45-5
Synonyms: HCFU
Carmofur (HCFU) is a rat recombinant acid ceramidase inhibitor with an IC50 of 29 nM. Carmofur is also a protease inhibitor of SARS-CoV-2 main protease (Mpro), fatty acid amide hydrolase (FAAH) and N-acylethanolamine acid amidase (NAAA). Carmofur has anti-cancer, anti-inflammatory and anti-virus activities, and can be used for the study of COVID-19 and acute lung injury (ALI) .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-15250
CAS No.: 1210004-12-8
Purity:  99.75%
Target:  

FAAH MAGL Autophagy

Research Areas:  

Neurological Disease

JZL195 is a selective and efficacious dual fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) inhibitor with IC50s of 2 and 4 nM, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-10865
CAS No.: 874902-19-9
Purity:  98.01%
Target:  

FAAH Autophagy

Research Areas:  

Neurological Disease

LY2183240 is a highly potent blocker of anandamide uptake (IC50= 270 pM; Ki=540 nM). LY2183240 is a potent, covalent inhibitor of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) with an IC50 of 12.4 nM. LY2183240 inactivates FAAH by carbamylation of the enzyme's serine nucleophile. LY2183240 also inhibits several other brain serine hydrolases with IC50s of 5.3, 0.09, 8.2 nM for MAG lipase, bh6 and KIAA1363, respectively .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-14380
CAS No.: 1196109-52-0
Purity:  99.95%
Target:  

FAAH Autophagy

Research Areas:  

Inflammation/Immunology Cancer

PF-3845 is a potent, selective, irreversible and orally active inhibitor of fatty acid amide hydrolase (FAAH), with a Ki of 0.23 μM. PF-3845 is a covalent inhibitor that carbamylates FAAH's serine nucleophile. PF-3845 can reduce pain sensation, inflammation, and anxiety/depression without substantial effects on motility or cognition .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-119283
CAS No.: 359714-55-9
Purity:  99.58%
Synonyms: MAGL-IN-5
CAY10499 (MAGL-IN-5) is a non-selective lipase inhibitor with IC50 values of 144 nM and 14 nM for monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), respectively. Additionally, CAY10499 exhibits anti-inflammatory and antiviral activities .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-19740
CAS No.: 1233855-46-3
Target:  

FAAH Autophagy

Research Areas:  

Neurological Disease

BIA 10-2474 is an inhibitor of fatty acid amide hydrolase (FAAH) with IC50 values of 50 to 70mg/kg in various rat brain regions.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N2365
CAS No.: 74058-71-2
Synonyms: N-BenzylpalmitAmide; N-BenzylhexadecanAmide; MacAmide 1
Macamide B (N-Benzylhexadecanamide; Macamide 1) is a macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH).
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N3033
CAS No.: 883715-18-2
N-​Benzyllinolenamide is a natural macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH) with an IC50 of 41.8 μM .
loading...
    loading...
Cat. No.: HY-110138
CAS No.: 861891-72-7
Purity:  99.70%
Target:  

FAAH

Research Areas:  

Others

PDP-EA is a compound that increases the amidohydrolase activity of FAAH (fatty acid amide hydrolase) .
loading...
    loading...
Cat. No.: HY-18081
CAS No.: 959151-50-9
Target:  

FAAH

Research Areas:  

Metabolic Disease

PF 750 is a selective, covalent and brain-penetrant fatty acid amide hydrolase (FAAH) inhibitor. PF 750 covalently carbamylates FAAH's catalytic serine nucleophile to inactivate the enzyme .
loading...
    loading...
Cat. No.: HY-N7062
CAS No.: 681136-29-8
Synonyms: Takeda-25
Target:  

FAAH

Research Areas:  

Neurological Disease

JNJ-1661010 (Takeda-25) a potent and selective fatty acid amide hydrolase (FAAH) inhibitor with IC50s of 34 and 33 nM for rat FAAH and human FAAH, respectively. JNJ-1661010 can cross the blood-brain barrier and used as broad-spectrum analgesics .
loading...
    loading...
Cat. No.: HY-120961
CAS No.: 85075-82-7
Synonyms: N-EthyloleAmide
Target:  

FAAH

Research Areas:  

Metabolic Disease

Oleoyl ethyl amide (N-Ethyloleamide) is a fatty acid amide hydrolase (FAAH) inhibitor. Oleoyl ethyl amide can counteract bladder overactivity .
loading...
    loading...
Cat. No.: HY-101457
CAS No.: 1672691-74-5
Purity:  99.74%
Target:  

MAGL

Research Areas:  

Metabolic Disease

JZP-430 is a potent, highly selective, irreversible inhibitor of α/β-hydrolase domain 6 (ABHD6) with an IC50 of 44 nM, exhibits ~230-fold selectivity over fatty acid amide hydrolase (FAAH) and lysosomal acid lipase (LAL) .
loading...
    loading...
Cat. No.: HY-125967
CAS No.: 86855-26-7
Purity:  ≥97.0%
Target:  

FAAH

Research Areas:  

Neurological Disease

AM 374 is an fatty acid amide hydrolase (FAAH) inhibitor. AM 374 inhibits amidase activity with an IC50 value of 13 nM. AM 374 can be used for the research of neurological disease .
loading...
    loading...
Cat. No.: HY-160207
CAS No.: 2156649-32-8
Synonyms: MA-JD21; ABX-002
Elunetirom (MA-JD21) is an orally active, blood-brain barrier-permeable prodrug of LL-340001. Elunetirom employs fatty acid amide hydrolase (FAAH)-dependent prodrug technology to enhance the brain delivery of LL-340001, a potent thyroid hormone receptor agonist with 15-fold higher selectivity for TRβ over TRα. Elunetirom induces T3-regulated gene expression, including that of ABCD2. Elunetirom drives neuroplasticity and bioenergetic changes, and induces neurogenesis, neuritogenesis, and synaptogenesis. Elunetirom is applicable to research related to major depressive disorder and X-linked adrenoleukodystrophy .
loading...
    loading...
Cat. No.: HY-120957
CAS No.: 862913-13-1
Synonyms: AMC-AA; 7-Amino-4-methyl coumarin-arachidonAmide
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

AMC arachidonoyl amide (AMC-AA) is one of several fatty acid amides which can be used to measure fatty acid amide hydrolase (FAAH) activity.1 FAAH is a relatively unselective enzyme in that it accepts a variety of amide head groups other than the ethanolamine of its nominal endogenous substrate anandamide.2 Exposure of AMC-AA to FAAH activity results in the release of the fluorescent aminomethyl coumarin that absorbs at 360 nm and emits at 465 nm. This allows the fast and convenient measurement of FAAH activity using a simple cuvette or microplate fluorometer.
loading...
    loading...
Cat. No.: HY-103462
CAS No.: 1304778-15-1
Purity:  99.75%
TC-F2 is a reversible non-covalent binding inhibitor of fatty acid amide hydrolase (FAAH) with an IC50 of 28 nM. FAAH is involved in many human diseases, particularly cancer, pain and inflammation as well as neurological, metabolic and cardiovascular disorders .
loading...
    loading...
Cat. No.: HY-110018
CAS No.: 199875-69-9
Purity:  98.36%
N-Arachidonyldopamine acts as an Anandamide (HY-10863) membrane transport inhibitor, a selective CB1 cannabinoid receptor agonist, and a VR1 receptor activator. It exhibits an EC50 value of 48 nM for rat VR1 and a Ki value of 0.25 μM for CB1. N-Arachidonyldopamine exists in mammalian neural tissues. It stimulates intracellular Ca 2+ mobilization, mediates cannabinoid-like effects, and induces hypothermia, hypomotility, catalepsy, analgesia, and hyperalgesia to heat. N-Arachidonyldopamine possesses anticancer activity against breast cancer. It can be used in research related to breast cancer and heat hyperalgesia .
loading...
    loading...
Cat. No.: HY-121422
CAS No.: 1680193-80-9
Purity:  99.72%
Target:  

MAGL Histamine Receptor

Research Areas:  

Inflammation/Immunology

JZP-361 is a potent, reversible and selective inhibitor of human recombinant MAGL (hMAGL) with an IC50 of 46 nM. JZP-361 also shows antihistaminergic activities and can be used for asthma research .
loading...
    loading...